Lamotrigine induced DRESS syndrome

Area of Science:

• Clinical Medicine
• Pharmacology
• Immunology

Background:

• Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe, delayed hypersensitivity reaction to medications.
• Characterized by dermatological, hematological, and visceral manifestations, DRESS syndrome poses a significant mortality risk.
• Lamotrigine, an anticonvulsant, is a potential trigger for DRESS syndrome.

Observation:

• A 12-year-old boy presented with symptoms consistent with DRESS syndrome.
• The patient developed the condition following treatment with Lamotrigine.
• Clinical presentation included characteristic skin eruption, fever, lymphadenopathy, and systemic involvement.

Findings:

• The case confirmed Lamotrigine as the causative agent for DRESS syndrome in this pediatric patient.
• Prompt identification and cessation of the offending drug led to a favorable clinical outcome.
• The patient experienced a rapid recovery following early medical intervention.

Implications:

• This case underscores the critical importance of early recognition and management of DRESS syndrome.
• Awareness of Lamotrigine-induced DRESS syndrome is vital for clinicians managing pediatric patients.
• Timely intervention can significantly improve prognosis and prevent fatal outcomes in DRESS syndrome.